Related Experiment Video
Updated: Jun 28, 2025
14:56
The Combined Use of Transcranial Direct Current Stimulation and Robotic Therapy for the Upper Limb
Published on: September 23, 2018
9.0K
Revolutionizing Neurological Disorder Treatment: Integrating Innovations in Pharmaceutical Interventions and Advanced
1Pharma Innovation Lab., Department of Pharmaceutical Sciences & Technology, Maharaja Ranjit Singh Punjab Technical University, Bathinda 151001, India.
Current Pharmaceutical Design
|April 15, 2024
Summary
Recent pharmaceutical advancements offer new hope for treating neurological disorders like Alzheimer's and Parkinson's disease. Innovations in drug delivery and gene therapy promise more effective, personalized treatments for brain conditions.
Area of Science:
- Neuroscience
- Pharmacology
- Biotechnology
Background:
- Neurological disorders significantly impact quality of life and cause disability.
- Pharmaceutical interventions have seen recent advancements in treating these conditions.
Purpose of the Study:
- To review the latest innovations and breakthroughs in treating neurological disorders.
- To focus on key therapeutic areas including Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke.
Main Methods:
- Exploration of emerging trends in drug development, novel therapeutic targets, and drug delivery systems.
- Review of personalized medicine approaches and advanced therapeutic technologies like gene therapy, optogenetics, and neurostimulation.
- Analysis of technologies for neural circuit modulation and neuronal function restoration.
Main Results:
- Identification of novel therapeutic targets and innovative drug delivery systems.
- Integration of advanced technologies such as gene therapy and neurostimulation for precise neural modulation.
- Demonstration of potential for disease modification and restoration of neuronal function.
Conclusions:
- Advancements offer prospects for more effective and tailored treatments for neurological disorders.
- Challenges remain in diagnostic tools, target identification, and drug delivery optimization.
- Continued research and collaboration are crucial to revolutionize neurological disorder treatment.
Related Concept Videos
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:29Drug Delivery: Parenteral Route
507
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
507
01:14Brain Imaging
228
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
228
01:26Drug Administration and Therapy Phases: Overview
454
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
454
01:26Psychosis: Goals of Pharmacotherapy
124
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
124
01:22Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183